|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1810 News |
|
| «12345678910111213...3132» |
- | Trial completion: Media Literacy to Prevent Adolescent Smoking (clinicaltrials.gov) - Jul 26, 2017
P=N/A, N=1211, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed
- Enrollment change, Trial primary completion date: A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward (clinicaltrials.gov) - Jul 21, 2017
P1, N=29, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed N=40 --> 29 | Trial primary completion date: Dec 2008 --> Mar 2009
- | quetiapine / Generic mfg.
Enrollment change: Effect of Quetiapine on Marijuana Withdrawal and Relapse (clinicaltrials.gov) - Jul 12, 2017
P2, N=14, Completed, Sponsor: New York State Psychiatric Institute
N=40 --> 29 | Trial primary completion date: Dec 2008 --> Mar 2009 N=20 --> 14
- | Chantix (varenicline) / Pfizer
Trial primary completion date: Effect of Varenicline on Tobacco Addiction and on Abstinence-induced Cognitive Impairment (clinicaltrials.gov) - Jul 7, 2017
P1, N=0, Withdrawn, Sponsor: National Institute on Drug Abuse (NIDA)
N=20 --> 14 Trial primary completion date: Mar 2014 --> Nov 2014
- | Trial completion, Enrollment change: SDAT: Smoking Cessation for Depression and Anxiety Treatment (clinicaltrials.gov) - Jul 7, 2017
P1, N=12, Completed, Sponsor: University of Houston
Trial primary completion date: Mar 2014 --> Nov 2014 Recruiting --> Completed | N=60 --> 12
- | Trial completion, Phase classification: Assessment of Chiropractic Treatment for Low Back Pain and Smoking Cessation in Military Active Duty Personnel. (clinicaltrials.gov) - Jul 7, 2017
P=N/A, N=750, Completed, Sponsor: RAND
Recruiting --> Completed | N=60 --> 12 Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A
- | Enrollment closed: Reduced Nicotine Content Cigarettes in Smokers of Lower Socioeconomic Status (clinicaltrials.gov) - Jul 2, 2017
P=N/A, N=400, Active, not recruiting, Sponsor: Milton S. Hershey Medical Center
Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A Recruiting --> Active, not recruiting
- | Trial completion, Trial primary completion date: The Effect of a High Protein Diet Versus a Low Fat Diet on Body Weight After Smoking Cessation (clinicaltrials.gov) - Jun 29, 2017
P=N/A, N=122, Completed, Sponsor: Oslo University Hospital
Recruiting --> Active, not recruiting Recruiting --> Completed | Trial primary completion date: Sep 2012 --> Aug 2013
- | Trial primary completion date: BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit (clinicaltrials.gov) - Jun 27, 2017
P=N/A, N=331, Active, not recruiting, Sponsor: Duke University
Recruiting --> Completed | Trial primary completion date: Sep 2012 --> Aug 2013 Trial primary completion date: May 2017 --> Aug 2017
- | Trial completion, Trial primary completion date: Effects of Yoga and Cardiovascular Exercise on Smoking Motivation (clinicaltrials.gov) - Jun 26, 2017
P=N/A, N=79, Completed, Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Trial primary completion date: May 2017 --> Aug 2017 Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> May 2011
- | Enrollment change: Nicotine Metabolism and Low Nicotine Cigarettes (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=207, Active, not recruiting, Sponsor: University of Pennsylvania
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> May 2011 N=100 --> 207
- | Trial completion, Enrollment change, Trial primary completion date: Enhanced Smoking Cessation for University Students (clinicaltrials.gov) - Jun 22, 2017
P=N/A, N=39, Completed, Sponsor: M.D. Anderson Cancer Center
N=100 --> 207 Active, not recruiting --> Completed | N=200 --> 39 | Trial primary completion date: Jun 2018 --> Jun 2017
- | Enrollment closed: Countering Young Adult Tobacco Marketing in Bars (clinicaltrials.gov) - Jun 16, 2017
P=N/A, N=25200, Active, not recruiting, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed | N=200 --> 39 | Trial primary completion date: Jun 2018 --> Jun 2017 Recruiting --> Active, not recruiting
- | Chantix (varenicline) / Pfizer
Enrollment change: Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation (clinicaltrials.gov) - Jun 5, 2017
P1/2, N=74, Completed, Sponsor: Johns Hopkins University
Recruiting --> Active, not recruiting N=200 --> 74
- | Chantix (varenicline) / Pfizer
Trial completion: Smoking Habits and Smoking Cessation in Young Adults (clinicaltrials.gov) - Jun 4, 2017
P2/3, N=300, Completed, Sponsor: Tuula Toljamo
N=200 --> 74 Active, not recruiting --> Completed
- | Trial completion: Behavioral Therapy for Reduction in Smoking Craving (clinicaltrials.gov) - May 31, 2017
P=N/A, N=40, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment closed, Enrollment change: BABY STEPS II: SMS Scheduled Gradual Reduction Text Messages to Help Pregnant Smokers Quit (clinicaltrials.gov) - May 30, 2017
P=N/A, N=331, Active, not recruiting, Sponsor: Duke University
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=522 --> 331
- | Trial completion, Enrollment change: Effects of Marijuana Used on Lung Function in Persons With Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - May 15, 2017
P=N/A, N=200, Completed, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Active, not recruiting | N=522 --> 331 Recruiting --> Completed | N=300 --> 200
- | bupropion / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Effectiveness of Bupropion for Smokers Recovering From Alcohol Dependence (clinicaltrials.gov) - May 15, 2017
P3, N=143, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed | N=300 --> 200 Recruiting --> Completed | N=236 --> 143 | Trial primary completion date: Jul 2009 --> Feb 2010
- ||| Chantix (varenicline) / Pfizer
Trial completion, Trial primary completion date: Smoking Cessation Program in the Preadmission Clinic (clinicaltrials.gov) - May 4, 2017
P=N/A, N=296, Completed, Sponsor: University Health Network, Toronto
Recruiting --> Completed | N=236 --> 143 | Trial primary completion date: Jul 2009 --> Feb 2010 Active, not recruiting --> Completed | Trial primary completion date: Aug 2017 --> Apr 2017
- | Trial completion: Culturally Targeted & Individually Tailored Smoking Cessation Study: LGBT Smokers (clinicaltrials.gov) - May 3, 2017
P=N/A, N=400, Completed, Sponsor: University of Illinois at Chicago
Active, not recruiting --> Completed | Trial primary completion date: Aug 2017 --> Apr 2017 Active, not recruiting --> Completed
- | Trial primary completion date: Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients (clinicaltrials.gov) - May 3, 2017
P4, N=20, Enrolling by invitation, Sponsor: University of Cincinnati
Active, not recruiting --> Completed Trial primary completion date: Nov 2016 --> Mar 2018
- | Trial completion: SEHAT: Study of a Community Based Approach to Control Cardiovascular Risk Factors in India (clinicaltrials.gov) - May 3, 2017
P=N/A, N=1242, Completed, Sponsor: University Hospitals Cleveland Medical Center
Trial primary completion date: Nov 2016 --> Mar 2018 Active, not recruiting --> Completed
- |||| Chantix (varenicline) / Pfizer
Trial completion: Understanding Disparities in Quitting in African American and White Smokers (clinicaltrials.gov) - May 3, 2017
P4, N=449, Completed, Sponsor: Nikki Nollen, PhD, MA
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial primary completion date: D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking) (clinicaltrials.gov) - May 1, 2017
P2, N=0, Withdrawn, Sponsor: Boston University Charles River Campus
Active, not recruiting --> Completed Trial primary completion date: Jan 2014 --> Jul 2015
- | Trial primary completion date: D-cycloserine (DCS) Pretreatment + CBT + Nicotine Replacement Therapy for Smoking Cessation (DCS) (clinicaltrials.gov) - Apr 27, 2017
P1/2, N=40, Recruiting, Sponsor: Mclean Hospital
Trial primary completion date: Jan 2014 --> Jul 2015 Trial primary completion date: Mar 2017 --> Aug 2017
- | Trial completion, Trial primary completion date: Study of Effectiveness of Adding the Health Promotion and Rehabilitation for Treatment for Alcohol and Drug Abusers (clinicaltrials.gov) - Apr 27, 2017
P=N/A, N=214, Completed, Sponsor: Skane University Hospital
Trial primary completion date: Mar 2017 --> Aug 2017 Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Sep 2015
- | Trial completion, Trial primary completion date: Healthier Hearts and Brains in Treating Smoking: The HABITS Study (clinicaltrials.gov) - Apr 27, 2017
P=N/A, N=79, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Sep 2015 Recruiting --> Completed | Trial primary completion date: Jun 2010 --> Dec 2010
- | naltrexone / Generic mfg.
Enrollment change: Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) (clinicaltrials.gov) - Apr 20, 2017
P4, N=60, Completed, Sponsor: The Scripps Research Institute
Recruiting --> Completed | Trial primary completion date: Jun 2010 --> Dec 2010 N=166 --> 60
- | Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: Computer-Based Program to Facilitate Readiness and Motivation for Smoking Cessation (clinicaltrials.gov) - Apr 20, 2017
P=N/A, N=0, Withdrawn, Sponsor: University of Oklahoma
N=166 --> 60 N=150 --> 0 | Initiation date: Apr 2012 --> Jun 2010 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2012 --> Nov 2014
- | naltrexone / Generic mfg.
Trial completion: Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) (clinicaltrials.gov) - Apr 19, 2017
P4, N=60, Completed, Sponsor: The Scripps Research Institute
N=150 --> 0 | Initiation date: Apr 2012 --> Jun 2010 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jul 2012 --> Nov 2014 No longer recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Trial primary completion date: Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers (clinicaltrials.gov) - Apr 18, 2017
P2, N=39, Completed, Sponsor: UNC Lineberger Comprehensive Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> May 2016
- | Trial completion, Trial primary completion date: Smoking Cessation in Women With Gynecological Conditions (clinicaltrials.gov) - Apr 16, 2017
P=N/A, N=31, Completed, Sponsor: University of Oklahoma
Active, not recruiting --> Completed | Trial primary completion date: Sep 2017 --> May 2016 Active, not recruiting --> Completed | Trial primary completion date: Apr 2016 --> Apr 2017
- | Phase classification: Integrated Treatment for Smoking Cessation & Anxiety in People With HIV (clinicaltrials.gov) - Apr 14, 2017
P=N/A, N=72, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed | Trial primary completion date: Apr 2016 --> Apr 2017 Phase classification: P1 --> P=N/A
- | Chantix (varenicline) / Pfizer
Enrollment change, Real-world evidence, Real-world: Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling (clinicaltrials.gov) - Apr 13, 2017
P4, N=738, Completed, Sponsor: Ottawa Heart Institute Research Corporation
Phase classification: P1 --> P=N/A N=1068 --> 738
- | Trial initiation date, Trial primary completion date: Novel Methods to Reduce Children's Secondhand Smoke Exposure II (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=74, Active, not recruiting, Sponsor: University of Oklahoma
N=1068 --> 738 Initiation date: Jun 2013 --> Nov 2012 | Trial primary completion date: Feb 2014 --> Mar 2017
- | Trial completion, Phase classification, Enrollment change: SSTOP: Smoking Cessation Intervention for Diabetic Patients (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=20, Completed, Sponsor: Rhode Island Hospital
Initiation date: Jun 2013 --> Nov 2012 | Trial primary completion date: Feb 2014 --> Mar 2017 Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=72 --> 20
- | Trial primary completion date, Surgery: STOP-OP: Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=110, Recruiting, Sponsor: Rigshospitalet, Denmark
Recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=72 --> 20 Trial primary completion date: Mar 2017 --> Mar 2018
- | Trial completion, Trial primary completion date: OCAST Cessation Study (clinicaltrials.gov) - Apr 11, 2017
P=N/A, N=152, Completed, Sponsor: University of Oklahoma
Trial primary completion date: Mar 2017 --> Mar 2018 Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Dec 2016
- | Trial primary completion date: Evaluation of Transdermal Nicotine Replacement Therapy (NRT) Activity Through Metabolic Induction (clinicaltrials.gov) - Apr 10, 2017
P1, N=52, Completed, Sponsor: The Queen Elizabeth Hospital
Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Dec 2016 Trial primary completion date: Jul 2013 --> Jul 2015
- | Enrollment change, Trial primary completion date: Improving Health for Aboriginal People Through Tobacco Related Research (clinicaltrials.gov) - Apr 10, 2017
P=N/A, N=16, Completed, Sponsor: The Queen Elizabeth Hospital
Trial primary completion date: Jul 2013 --> Jul 2015 N=84 --> 16 | Trial primary completion date: May 2014 --> Apr 2016
- | Chantix (varenicline) / Pfizer
Trial completion, Enrollment change: VANQUISH: Smoking Study With Behavioral Therapy for Hypertensive Patients (clinicaltrials.gov) - Apr 10, 2017
P4, N=203, Completed, Sponsor: UConn Health
N=84 --> 16 | Trial primary completion date: May 2014 --> Apr 2016 Active, not recruiting --> Completed | N=260 --> 203
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: Tobacco Use Among Arab American Youth (clinicaltrials.gov) - Apr 7, 2017
P=N/A, N=2300, Completed, Sponsor: Wayne State University
Active, not recruiting --> Completed | N=260 --> 203 Recruiting --> Completed | N=4000 --> 2300
- | Enrollment change, Trial primary completion date: Duration of Follow-Up Counselling on Smoking Cessation Outcomes (clinicaltrials.gov) - Apr 7, 2017
P=N/A, N=11, Completed, Sponsor: National University Hospital, Singapore
Recruiting --> Completed | N=4000 --> 2300 N=124 --> 11 | Trial primary completion date: Jun 2015 --> Mar 2016
- | aspirin / Generic mfg.
Phase classification, Enrollment change, Trial primary completion date: Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male Smokers (clinicaltrials.gov) - Apr 4, 2017
P, N=6, Completed, Sponsor: Vanderbilt University
N=124 --> 11 | Trial primary completion date: Jun 2015 --> Mar 2016 Phase classification: P=N/A --> P | N=38 --> 6 | Trial primary completion date: Aug 2013 --> Feb 2016
- ||| Chantix (varenicline) / Pfizer
Enrollment closed: Smoking Cessation Study In Healthy Adolescent Smokers (clinicaltrials.gov) - Mar 24, 2017
P4, N=300, Active, not recruiting, Sponsor: Pfizer
Phase classification: P=N/A --> P | N=38 --> 6 | Trial primary completion date: Aug 2013 --> Feb 2016 Recruiting --> Active, not recruiting
- | Trial primary completion date: Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy (clinicaltrials.gov) - Mar 20, 2017
P1, N=80, Recruiting, Sponsor: Wayne State University
Recruiting --> Active, not recruiting Trial primary completion date: May 2017 --> Oct 2017
- | Phase classification, Trial primary completion date: Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) - Mar 10, 2017
P3, N=566, Active, not recruiting, Sponsor: Butler Hospital
Trial primary completion date: May 2017 --> Oct 2017 Phase classification: P4 --> P3 | Trial primary completion date: Aug 2016 --> Aug 2017
- | Trial completion: STQ FB: Striving to Quit: First Breath (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=3100, Completed, Sponsor: University of Wisconsin, Madison
Phase classification: P4 --> P3 | Trial primary completion date: Aug 2016 --> Aug 2017 Active, not recruiting --> Completed
- | Trial completion, Trial primary completion date: CHOICE: Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients (clinicaltrials.gov) - Mar 1, 2017
P=N/A, N=250, Completed, Sponsor: Guangdong Association of Clinical Trials
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jun 2014 --> May 2016